Phase I Trial of Silymarin for Chronic Liver Diseases

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2006
The purpose of this study is to determine the safety and tolerability of different dosages of silymarin on subjects with Hepatitis C or Non-Alcoholic Fatty Liver Disease.
Epistemonikos ID: 15c30864144e39208d326c41d2cfd3e351d1c988
First added on: May 04, 2024